Showing results (61-70 of 115) with videos related to
Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|May 21, 2014
Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell cultureAdriaan H de Wilde, Dirk Jochmans, Clara C Posthuma, et al.Antiviral Research|June 29, 2021
A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agentsThuc Nguyen Dan Do, Kim Donckers, Laura Vangeel, et al.Molecular Diversity|October 17, 2022
Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agentsSaida Lachhab, Az-Eddine El Mansouri, Ahmad Mehdi, et al.European Journal of Medicinal Chemistry|May 7, 2021
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptorsMaria Chiara Pismataro, Tommaso Felicetti, Chiara Bertagnin, et al.Antiviral Research|October 14, 2023
Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411Robert Konkel, Aleksandra Milewska, Nguyen Dan Thuc Do, et al.ACS Medicinal Chemistry Letters|October 15, 2025
Identification and Exploration of a Series of SARS-Cov‑2 MPro Cyano-Based Inhibitors Revealing Ortho-Substitution Effects within the P3 Biphenyl GroupEmma Clyde-Allen, Mikołaj Zmudzinski, Mohammad Afsar, et al.European Journal of Medicinal Chemistry|February 20, 2024
Design, synthesis, and molecular modeling studies of novel 2-quinolone-1,2,3-triazole-α-aminophosphonates hybrids as dual antiviral and antibacterial agentsKhadija El Gadali, Meriem Rafya, Az-Eddine El Mansouri, et al.Journal of Virology|October 6, 2006
Indolopyridones inhibit human immunodeficiency virus reverse transcriptase with a novel mechanism of actionDirk Jochmans, Jérôme Deval, Bart Kesteleyn, et al.Plos Biology|June 12, 2019
A novel druggable interprotomer pocket in the capsid of rhino- and enterovirusesRana Abdelnabi, James A Geraets, Yipeng Ma, et al.Journal of Virology|August 22, 2008
Resistance mutations in human immunodeficiency virus type 1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitorsOlivia Goethals, Reginald Clayton, Marcia Van Ginderen, et al.Pageof 12